acri_10q-033109.htm
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
10-Q
Mark
One
x
|
QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
1934
|
FOR THE
QUARTERLY PERIOD ENDED MARCH 31, 2009
Or
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
1934
|
FOR THE
TRANSITION PERIOD FROM
TO
Commission
File Number: 0-26068
ACACIA
RESEARCH CORPORATION
(Exact
name of registrant as specified in its charter)
|
|
DELAWARE
|
95-4405754
|
(State
or other jurisdiction of
incorporation
or organization)
|
(IRS
Employer
Identification
No.)
|
500
Newport Center Drive, Newport Beach, California 92660
(Address
of principal executive offices)
(949)
480-8300
(Registrant’s
telephone number, including area code)
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. x Yes o No
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such
files). o Yes o No
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act:
|
|
Large
accelerated filer o
|
Accelerated
filer x
|
Non-accelerated
filer o (Do not check if
a smaller reporting company)
|
Smaller reporting company o
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes o No x
As of May
6, 2009, 31,964,994 shares of the registrant’s common stock, $0.001 par value,
were issued and outstanding.
ACACIA
RESEARCH CORPORATION
Table
of Contents
Part
I. Financial Information
|
|
|
|
|
|
|
|
Item
1.
|
Financial
Statements
|
|
|
|
|
|
Consolidated Balance Sheets as of
March 31, 2009 and
December 31, 2008
(Unaudited)
|
1
1 11
|
|
|
|
|
Consolidated Statements of
Operations and Comprehensive Income (Loss) for the
Three Months Ended March 31, 2009
and 2008 (Unaudited)
|
2
|
|
|
|
|
Consolidated Statements of Cash
Flows for the Three Months Ended
March 31, 2009 and 2008
(Unaudited)
|
3
|
|
|
|
|
Notes to Consolidated Financial
Statements (Unaudited)
|
4
|
|
|
|
|
|
|
Item
2.
|
Management’s Discussion and
Analysis of Financial Condition and
Results of
Operations
|
10
|
|
|
|
Item
3.
|
Quantitative and Qualitative
Disclosures About Market Risk
|
17
|
|
|
|
Item
4.
|
Controls and
Procedures
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
Part
II. Other Information
|
|
|
|
|
|
|
|
Item
6.
|
Exhibits
|
18
|
|
|
|
|
|
|
Signatures
|
19
|
|
|
Exhibit
Index
|
20
|
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
(In
thousands, except share and per share information)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March
31,
|
|
|
December
31,
|
|
|
|
2009
|
|
|
2008
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$ |
50,878 |
|
|
$ |
48,279 |
|
Accounts
receivable
|
|
|
9,390 |
|
|
|
7,436 |
|
Deferred
royalties and contingent legal fees
|
|
|
1,604 |
|
|
|
- |
|
Prepaid
expenses and other current assets
|
|
|
703 |
|
|
|
1,255 |
|
Total
current assets
|
|
|
62,575 |
|
|
|
56,970 |
|
|
|
|
|
|
|
|
|
|
Property
and equipment, net of accumulated depreciation
|
|
|
196 |
|
|
|
221 |
|
Patents,
net of accumulated amortization
|
|
|
11,516 |
|
|
|
12,419 |
|
Investments
- noncurrent
|
|
|
3,123 |
|
|
|
3,239 |
|
Other
assets
|
|
|
1,119 |
|
|
|
225 |
|
|
|
$ |
78,529 |
|
|
$ |
73,074 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable and accrued expenses
|
|
$ |
3,799 |
|
|
$ |
3,240 |
|
Royalties
and contingent legal fees payable
|
|
|
12,089 |
|
|
|
10,770 |
|
Deferred
revenues
|
|
|
3,293 |
|
|
|
318 |
|
Total
current liabilities
|
|
|
19,181 |
|
|
|
14,328 |
|
|
|
|
|
|
|
|
|
|
Deferred
revenues, net of current portion
|
|
|
1,026 |
|
|
|
- |
|
Other
liabilities
|
|
|
212 |
|
|
|
199 |
|
Total
liabilities
|
|
|
20,419 |
|
|
|
14,527 |
|
|
|
|
|
|
|
|
|
|
Commitments
and contingencies (Note 6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
Preferred
stock, par value $0.001 per share; 10,000,000
|
|
|
|
|
|
|
|
|
shares
authorized; no shares issued or outstanding
|
|
|
- |
|
|
|
- |
|
Common
stock, par value $0.001 per share; 100,000,000 shares
|
|
|
|
|
|
|
|
|
authorized;
31,964,994 and 30,884,994 shares issued and outstanding
|
|
|
|
|
|
as
of March 31, 2009 and December 31, 2008, respectively
|
|
|
32 |
|
|
|
31 |
|
Additional
paid-in capital
|
|
|
169,387 |
|
|
|
167,468 |
|
Accumulated
deficit
|
|
|
(111,309 |
) |
|
|
(108,952 |
) |
Total
stockholders' equity
|
|
|
58,110 |
|
|
|
58,547 |
|
|
|
$ |
78,529 |
|
|
$ |
73,074 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In
thousands, except share and per share information)
(Unaudited)
|
|
|
|
|
|
|
|
|
For
the Three Months Ended
|
|
|
|
March
31, 2009
|
|
|
March
31, 2008
|
|
|
|
|
|
|
|
|
License
fee revenues
|
|
$ |
12,650 |
|
|
$ |
9,048 |
|
|
|
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
Marketing,
general and administrative expenses (including non-cash stock
compensation
|
|
|
|
|
|
|
|
|
expense
of $1,920 and $1,829 for the three months ended March 31, 2009 and 2008,
respectively)
|
|
|
5,378 |
|
|
|
5,649 |
|
Inventor
royalties and contingent legal fees expense - patents
|
|
|
6,691 |
|
|
|
4,731 |
|
Legal
expenses - patents
|
|
|
1,361 |
|
|
|
1,016 |
|
Research,
consulting and other expenses - patents
|
|
|
761 |
|
|
|
977 |
|
Amortization
of patents
|
|
|
1,065 |
|
|
|
1,335 |
|
Total
operating expenses
|
|
|
15,256 |
|
|
|
13,708 |
|
Operating
loss
|
|
|
(2,606 |
) |
|
|
(4,660 |
) |
|
|
|
|
|
|
|
|
|
Other
income (expense):
|
|
|
|
|
|
|
|
|
Interest
income
|
|
|
52 |
|
|
|
455 |
|
Gain
on foreign currency translation
|
|
|
201 |
|
|
|
- |
|
Gain
(loss) on investments
|
|
|
34 |
|
|
|
(263 |
) |
Total
other income
|
|
|
287 |
|
|
|
192 |
|
Loss
from operations before income taxes
|
|
|
(2,319 |
) |
|
|
(4,468 |
) |
|
|
|
|
|
|
|
|
|
Provision
for income taxes
|
|
|
(38 |
) |
|
|
(21 |
) |
Net
loss
|
|
|
(2,357 |
) |
|
|
(4,489 |
) |
Unrealized
loss on short-term investments
|
|
|
- |
|
|
|
(1 |
) |
Comprehensive
loss
|
|
$ |
(2,357 |
) |
|
$ |
(4,490 |
) |
|
|
|
|
|
|
|
|
|
Loss
per common share:
|
|
|
|
|
|
|
|
|
Net
loss
|
|
$ |
(2,357 |
) |
|
$ |
(4,489 |
) |
Basic
and diluted loss per share
|
|
|
(0.08 |
) |
|
|
(0.15 |
) |
Weighted
average shares, basic and diluted
|
|
|
29,639,459 |
|
|
|
29,217,636 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(In
thousands)
(Unaudited)
|
|
For
the Three Months Ended
|
|
|
|
March
31, 2009
|
|
|
March
31, 2008
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
Net
loss
|
|
$ |
(2,357 |
) |
|
$ |
(4,489 |
) |
Adjustments
to reconcile net loss to net cash provided by (used in)
operating activities:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
1,097 |
|
|
|
1,368 |
|
Non-cash
stock compensation
|
|
|
1,920 |
|
|
|
1,829 |
|
(Gain)
loss on investments
|
|
|
(34 |
) |
|
|
263 |
|
Changes
in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(1,954 |
) |
|
|
(2,864 |
) |
Prepaid
expenses and other assets
|
|
|
(1,946 |
) |
|
|
(169 |
) |
Accounts
payable and accrued expenses
|
|
|
572 |
|
|
|
(90 |
) |
Royalties
and contingent legal fees payable
|
|
|
1,319 |
|
|
|
221 |
|
Deferred
revenues
|
|
|
4,001 |
|
|
|
51 |
|
Net
cash provided by (used in) operating activities from continuing
operations
|
|
|
2,618 |
|
|
|
(3,880 |
) |
Net
cash provided by operating activities from discontinued
operations
|
|
|
- |
|
|
|
2 |
|
Net
cash provided by (used in) operating activities
|
|
|
2,618 |
|
|
|
(3,878 |
) |
|
|
|
|
|
|
|
|
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchase
of property and equipment
|
|
|
(7 |
) |
|
|
(19 |
) |
Purchase
of available-for-sale investments
|
|
|
- |
|
|
|
(265 |
) |
Sale
of available-for-sale investments
|
|
|
150 |
|
|
|
5,225 |
|
Patent
acquisition costs
|
|
|
(162 |
) |
|
|
(1,558 |
) |
Net
cash provided by (used in) investing activities
|
|
|
(19 |
) |
|
|
3,383 |
|
|
|
|
|
|
|
|
|
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds
from the exercise of stock options
|
|
|
- |
|
|
|
111 |
|
Net
cash provided by financing activities
|
|
|
- |
|
|
|
111 |
|
|
|
|
|
|
|
|
|
|
Increase
(decrease) in cash and cash equivalents
|
|
|
2,599 |
|
|
|
(384 |
) |
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents, beginning
|
|
|
48,279 |
|
|
|
40,467 |
|
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents, ending
|
|
$ |
50,878 |
|
|
$ |
40,083 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. DESCRIPTION
OF BUSINESS AND BASIS OF PRESENTATION
Description of Business.
Acacia Research Corporation (“Acacia” or the “Company”) is comprised of
Acacia and its wholly owned operating subsidiaries. As used herein,
“Acacia” and the “Company” refer to Acacia Research Corporation and/or its
wholly owned operating subsidiaries. All intellectual property
acquisition, development, licensing and enforcement activities are conducted
solely by certain of Acacia’s wholly owned operating subsidiaries.
Acacia’s
operating subsidiaries acquire, develop, license and enforce patented
technologies. Acacia’s operating subsidiaries generate license fee
revenues and related cash flows from the granting of licenses for the use of
patented technologies that its operating subsidiaries own or
control. Acacia’s operating subsidiaries assist patent owners with
the prosecution and development of their patent portfolios, the protection of
their patented inventions from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, if necessary, with the
enforcement against unauthorized users of their patented technologies.
Currently, on a consolidated basis, Acacia’s operating subsidiaries own or
control the rights to over 100 patent portfolios, which include U.S. patents and
certain foreign counterparts, covering technologies used in a wide variety of
industries.
Basis of
Presentation. The accompanying consolidated financial
statements include the accounts of Acacia and its wholly owned operating
subsidiaries. Intercompany transactions and balances have been
eliminated in consolidation.
The
accompanying consolidated financial statements have been prepared in accordance
with accounting principles generally accepted in the United States of America
for interim financial information and with the instructions to Form 10-Q and
Rule 10-01 of Regulation S-X. Accordingly, certain information and
footnotes required by accounting principles generally accepted in the United
States of America in annual financial statements have been omitted or condensed
in accordance with quarterly reporting requirements of the Securities and
Exchange Commission (“SEC”). These interim consolidated financial
statements should be read in conjunction with the consolidated financial
statements and notes thereto for the year ended December 31, 2008, as reported
by Acacia in its Annual Report on Form 10-K. The year-end
consolidated balance sheet data was derived from audited financial statements
but does not include all disclosures required by accounting principles generally
accepted in the United States of America.
The
consolidated financial statements of Acacia include all adjustments of a normal
recurring nature which, in the opinion of management, are necessary for a fair
statement of Acacia’s financial position as of March 31, 2009, and results of
its operations and its cash flows for the interim periods
presented. The results of operations for the three months ended March
31, 2009 are not necessarily indicative of the results to be expected for the
entire fiscal year.
2. SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
Use of
Estimates. The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the consolidated financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual
results could differ from these estimates.
Concentrations. Three licensees accounted for
20%, 11% and 10% of license fee revenues recognized during the three months
ended March 31, 2009. One licensee accounted for
28% of license fee revenues and three licensees individually accounted for 10%
of license fee revenues recognized during the three months ended March 31, 2008.
Five licensees individually represented approximately 27%, 15%, 14%, 11% and 10%
of accounts receivable at March 31, 2009. Three licensees represented
approximately 27%, 24% and 19% of accounts receivable at December 31,
2008.
Stock-Based Compensation. The
compensation cost for all stock-based awards is measured at the grant date,
based on the fair value of the award, and is recognized as an expense in the
statements of operations, on a straight-line basis, over the employee’s
requisite service period (generally the vesting period of the equity award)
which is generally one to four years. The fair value of each option award
is estimated on the date of grant using a Black-Scholes option valuation
model. The fair value of restricted stock awards is determined by the
product of the number of shares granted and the grant date market price of the
underlying common stock. Stock-based compensation expense is recorded
only for those awards expected to vest using an estimated forfeiture
rate. Pre-vesting option forfeitures are estimated at the time of
grant and are reflected in stock-based compensation expense recognized in the
consolidated statements of operations and comprehensive loss (hereinafter
“consolidated statements of operations”).
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Fair Value
Measurements. Effective January 1, 2008, Acacia adopted
Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value
Measurements” (“SFAS No. 157”). SFAS No. 157 establishes a common
definition for fair value to be applied to U.S. generally accepted accounting
principles guidance requiring use of fair value, establishes a framework for
measuring fair value, and expands disclosure about such fair value
measurements. The adoption of SFAS No. 157 did not have a material
impact on Acacia’s consolidated financial position, results of operations and
cash flows.
SFAS No.
157 defines fair value as the price that would be received for an asset or the
exit price that would be paid to transfer a liability in the principal or most
advantageous market in an orderly transaction between market participants on the
measurement date. SFAS No. 157 also establishes a fair value hierarchy which
requires an entity to maximize the use of observable inputs, where available.
SFAS No. 157 established a three-level hierarchy of valuation techniques used to
measure fair value, defined as follows:
|
Level
1 -
|
Observable
Inputs: Quoted prices in active markets for identical
investments;
|
·
|
Level
2 -
|
Pricing
Models with Significant Observable Inputs: Other significant
observable inputs, including quoted prices for similar investments,
interest rates, credit risk, etc.;
and
|
·
|
Level
3 -
|
Unobservable
Inputs: Significant unobservable inputs, including the entity’s
own assumptions in determining the fair value of
investments.
|
SFAS
No. 157 requires the use of observable market inputs (quoted market prices)
when measuring fair value and requires a Level 1 quoted price to be used to
measure fair value whenever possible. Refer to Note 7 to these
consolidated financial statements for information on the estimation of fair
value for auction rate securities held as of March 31, 2009.
Impairment of Marketable
Securities. Acacia
reviews impairments associated with its investments in marketable securities in
accordance with Emerging Issues Task Force (“EITF”) 03-1 and Financial
Accounting Standards Board Staff Position (“FSP”) SFAS 115-1 and 124-1,
“The Meaning of Other-Than-Temporary-Impairment and Its Application to Certain
Investments,” to determine the classification of any impairment as “temporary”
or “other-than-temporary.” For investments classified as
available-for-sale, unrealized losses that are other than temporary are
recognized in the consolidated statements of operations. An
impairment is deemed other than temporary unless (a) Acacia has the ability and
intent to hold an investment for a period of time sufficient for recovery of its
carrying amount and (b) positive evidence indicating that the investment's
carrying amount is recoverable within a reasonable period of time outweighs any
evidence to the contrary. All available evidence, both positive and negative, is
considered to determine whether, based on the weight of that evidence, the
carrying amount of the investment is recoverable within a reasonable period of
time. Any recovery in fair value is not recorded in earnings until the security
is sold or otherwise disposed of. Refer to Note 7 to these
consolidated financial statements for disclosures regarding investments in
auction rate securities.
Income
Taxes. Income taxes are accounted for using an asset and
liability approach that requires the recognition of deferred tax assets and
liabilities for the expected future tax consequences of events that have been
recognized in Acacia’s consolidated financial statements or consolidated tax
returns. A valuation allowance is established to reduce deferred tax assets if
all, or some portion, of such assets will more than likely not be
realized. The tax provisions for the periods presented relate
primarily to state tax liabilities in jurisdictions where certain of Acacia’s
operating subsidiaries file separate state tax returns.
3. EARNINGS
PER SHARE
Earnings (Loss) Per
Share. Basic earnings per share is computed based upon the
weighted average number of common shares outstanding, excluding unvested
restricted stock. Diluted earnings per share is computed based upon
the weighted average number of common shares outstanding, including the dilutive
effect of common stock equivalents outstanding during the periods, using the
treasury stock method. Potentially dilutive common stock equivalents
primarily consist of employee stock options, unvested restricted stock, and
restricted stock units.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The
following table presents the weighted-average number of common shares
outstanding used in the calculation of basic and diluted loss per
share:
|
|
For
the Three Months Ended
|
|
|
|
March
31,
2009
|
|
|
March
31,
2008
|
|
Basic
and diluted weighted-average number of common shares
outstanding
|
|
|
29,639,459 |
|
|
|
29,217,636 |
|
All
outstanding stock options, nonvested restricted stock and restricted stock
units excluded from the computation
of diluted loss per share because the effect of inclusion would have been
anti-dilutive
|
|
|
5,971,465 |
|
|
|
5,643,600 |
|
4. PATENTS
Acacia’s
only identifiable intangible assets at March 31, 2009 and December 31, 2008, are
patents and patent rights. Patent related accumulated amortization
totaled $22,238,000 and $21,173,000 as of March 31, 2009 and December 31, 2008,
respectively.
Acacia’s
patents and patent rights have remaining estimated economic useful lives ranging
from one to seven years. The weighted-average remaining estimated
economic useful life of Acacia’s patents and patent rights is four
years. Annual aggregate amortization expense is estimated to be
$2,959,000 for the remainder of 2009, $3,555,000 in 2010, $2,657,000 in 2011,
$959,000 in 2012 and $727,000 in 2013. At March 31, 2009 and December
31, 2008, all acquired intangible assets were subject to
amortization.
For the
three months ended March 31, 2009 and 2008, Acacia incurred patent / patent
rights acquisition costs totaling $162,000 and $1,558,000,
respectively. The patents and patent rights acquired have estimated
economic useful lives of approximately one to seven years.
5. DEFERRED
REVENUES AND RELATED ROYALTIES AND CONTINGENT LEGAL FEES
Deferred
license fee revenues, representing upfront license fee payments received from
licensees at the beginning of the contractual license term, which are deferred
and amortized in the statements of operations as license fee revenues on a
straight-line basis over the applicable license term, increased to $4,319,000 at
March 31, 2009, compared to $318,000 at December 31, 2008. Related
deferred royalties and contingent legal fees expense, which are also amortized
in the statements of operations on a straight-line basis over the applicable
license term, totaled $1,604,000 at March 31, 2009. The noncurrent
portion of deferred royalties and contingent legal fees, totaling $615,000 at
March 31, 2009, is included in “Other assets – noncurrent.”
6. COMMITMENTS
AND CONTINGENCIES
Inventor
Royalties and Contingent Legal Expenses
In
connection with the acquisition of certain patents and patent rights, certain of
Acacia’s operating subsidiaries executed related agreements which grant to the
former owners of the respective patents or patent rights, the right to receive
inventor royalties based on future net license fee revenues (as defined in the
respective agreements) generated as a result of licensing the respective patents
or patent portfolios. Inventor royalties paid pursuant to the
agreements are expensed in the consolidated statements of operations in the
period that the related license fee revenues are recognized. In
certain instances, pursuant to the terms of the underlying inventor agreements,
costs paid by Acacia’s operating subsidiaries to acquire patents are recoverable
from future net revenues. Patent acquisition costs that are
recoverable from future net revenues are amortized over the estimated economic
useful life of the related patents, or as the prepaid royalties are earned by
the inventor, as appropriate, and the related expense is included in
amortization expense in the consolidated statements of
operations. Any unamortized patent acquisition costs recovered from
net revenues are expensed in the period recovered, and included in “Inventor
royalties and contingent legal fees – patents” in the consolidated statements of
operations.
Acacia’s
operating subsidiaries may retain the services of law firms that specialize in
intellectual property licensing and enforcement and patent law in connection
with their licensing and enforcement activities. These law firms may
be retained on a contingent fee basis in which the law firms are paid on a
scaled percentage of any negotiated license fees, settlements or judgments
awarded based on how and when the license fees, settlements or judgments are
obtained. In instances where there are no recoveries from potential
infringers (ie. license fees), no contingent legal fees are paid; however,
Acacia’s operating subsidiaries may be liable for certain out of pocket legal
costs incurred pursuant to the underlying legal services
agreement. Legal fees advanced by contingent law firms that are
required to be paid in the event that no license recoveries are obtained are
expensed as incurred and included in liabilities in the consolidated balance
sheet.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Patent
Enforcement and Other Litigation
Acacia is
subject to claims, counterclaims and legal actions that arise in the ordinary
course of business. Management believes that the ultimate liability
with respect to these claims and legal actions, if any, will not have a material
effect on Acacia’s consolidated financial position, results of operations or
cash flows. Certain of Acacia’s operating subsidiaries are often
required to engage in litigation to enforce their patents and patent
rights.
7. FAIR
VALUE MEASUREMENTS AND AUCTION RATE SECURITIES
As of
March 31, 2009, Acacia held investment grade auction rate securities with a par
value totaling $3,575,000. Acacia’s auction rate securities consist of high
credit quality securities issued by closed-end investment companies with
portfolio asset coverage of at least 200%, and auction rate investments backed
by student loans, issued under programs such as the Federal Family Education
Loan Program, all of which carry credit ratings of AAA (S&P and
Moody’s). Auction rate securities are classified as
available-for-sale securities and reflected at fair value in accordance with the
requirements of SFAS No. 157.
Historically,
Acacia’s auction rate securities were recorded at cost, which approximated their
fair market value due to their variable interest rates, which typically reset
every 7 to 35 days, despite the long-term nature of their stated contractual
maturities. The Dutch auction process that resets the applicable interest
rate at predetermined calendar intervals is intended to provide liquidity to the
holder of auction rate securities by matching buyers and sellers within a market
context enabling the holder to gain immediate liquidity by selling such
interests at par or rolling over their investment. If there is an imbalance
between buyers and sellers, the risk of a failed auction exists. Due
to current liquidity issues in the
global credit and capital markets, these securities have continued to experience
failed auctions since February 2008. In such case of a failure, the
auction rate securities continue to pay interest at the maximum contractual rate
in accordance with their terms; however, Acacia may not be able to access the
par value of the invested funds until a future auction of these investments is
successful, the security is called by the issuer, or a buyer is found outside of
the auction process.
As a
result of the failed auctions, there are no reliable current observable market
prices available for these securities for purposes of establishing fair market
value as of March 31, 2009. As a result, the fair values of these
securities are estimated utilizing an analysis of certain unobservable inputs
and by reference to a discounted cash flow analysis as of March 31,
2009. These analyses considered, among other items, the underlying
structure of each security, the collateral underlying the security investments,
the creditworthiness of the counterparty, the present value of future principal
and contractual interest payments discounted at rates considered to be
reflective of current market conditions, consideration of the probabilities of
default, continued auction failure, or repurchase or redemption at par for each
period, and estimates of the time period over which liquidity related issues
will be resolved. Observable market data for instruments with similar
characteristics to Acacia’s auction rate securities was also considered when
possible.
At March
31, 2009, the par value of auction rate securities collateralized by student
loan portfolios totaled $2,700,000. As a result of the liquidity
issues associated with the failed auctions, Acacia estimates that the fair value
of these auction rate securities no longer approximates their par
value. Due to the estimate that the market for these student loan
collateralized instruments may take in excess of twelve months to fully recover,
Acacia has classified these investments as noncurrent in the accompanying
consolidated balance sheets. Further, as a result of the analysis
described above, Acacia recorded an other-than-temporary loss of $263,000
in the accompanying statement of operations for the three months ended
March 31, 2008. As a result of partial redemptions at par on certain
of these auction rate securities subsequent to March 31, 2008, Acacia has
recovered $23,000 of the other-than-temporary loss originally recorded on these
securities. As of March 31, 2009, the net other-than-temporary loss
on auction rate securities collateralized by student loan portfolios totaled
$240,000.
At March
31, 2009, the par value of auction rate securities issued by high credit quality
closed-end investment companies totaled $875,000. Despite the
reduction in liquidity resulting from the failure of auctions for these
securities since February 2008, the issuers of these auction rate
securities have redeemed, at par, approximately 71% of the securities held by
Acacia since February 2008, and have indicated that they continue to evaluate
ways to provide additional liquidity to their auction rate security
holders. Additionally, these securities continue to be AAA rated and
the underlying funds continue to meet certain specified asset coverage tests
required by the rating agencies, as well as the 200% asset coverage test with
respect to auction rate securities set forth in the Investment Company Act of
1940, as amended. However, due to the impact of the reduced liquidity
associated with these securities as of March 31, 2009, Acacia has classified
these securities as noncurrent assets in the accompanying consolidated balance
sheets. Further, Acacia recorded an other-than-temporary loss on
auction rate securities issued by high credit quality closed-end investment
companies of $236,000 in the statement of operations for the three months ended
December 31, 2008. As a result of partial redemptions at par on
certain of these auction rate securities during the three months ended March 31,
2009, Acacia recovered $24,000 of the other-than-temporary loss originally
recorded on these securities. As of March 31, 2009, the net
other-than-temporary loss on auction rate securities issued by high credit
quality closed-end investment companies totaled $212,000.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Assets
measured at fair value on a recurring basis subject to the disclosure
requirements of SFAS No. 157 at March 31, 2009, were as follows (in
thousands):
|
|
|
|
Fair
Value Measurements at Reporting Date Using:
|
|
|
Balance
at
March
31,
|
|
Quoted
Prices
in
Active
Markets
For Identical
Assets
|
|
Significant
Other
Observable
Inputs
|
|
Significant
Unobservable
Inputs
|
Description
|
|
2009
|
|
(Level 1)
|
|
(Level 2)
|
|
(Level 3)
|
|
|
|
|
|
|
|
|
|
Auction
rate securities
|
|
$
|
3,123
|
|
-
|
|
-
|
|
$
|
3,123
|
As a
result of the change in market conditions, during the first quarter of 2008, we
modified the valuation methodology for auction rate securities to include
consideration of the factors discussed above and reference to a discounted cash
flow analysis. Accordingly, these securities changed from Level 1 to
Level 3 within the hierarchy prescribed by SFAS No. 157 since the initial
adoption of SFAS No. 157 on January 1, 2008.
The
following table presents the assets measured at fair value on a recurring basis
using significant unobservable inputs (Level 3) as defined in SFAS No. 157, for
the interim periods presented (in thousands):
|
|
For
the Three Months
|
|
|
|
Ended
March 31,
|
|
|
|
2009
|
|
|
2008
|
|
Auction rate
securities:
|
|
|
|
|
|
|
Beginning
balance as of January 1
|
|
$ |
3,239 |
|
|
$ |
- |
|
Transfers
to Level 3
|
|
|
- |
|
|
|
6,000 |
|
Total
gains or (losses) (realized or unrealized):
|
|
|
|
|
|
|
|
|
Included
in earnings – other income (expense)
|
|
|
34 |
|
|
|
(263 |
) |
Purchases
and settlements (net)
|
|
|
(150 |
) |
|
|
- |
|
Ending
balance as of March 31
|
|
$ |
3,123 |
|
|
$ |
5,737 |
|
8. RECENT
ACCOUNTING PRONOUNCEMENTS
In April
2009, the Financial Accounting Standards Board (“FASB”) issued FSP SFAS No.
157-4, “Determining Fair Value When the Volume and Level of Activity for the
Asset or Liability Have Significantly Decreased and Identifying Transactions
That Are Not Orderly,” (“FSP No. 157-4”) which provides additional guidance for
estimating fair value in accordance with SFAS No. 157 when the volume and level
of activity for the asset or liability have significantly
decreased. FSP No. 157-4 re-emphasizes that regardless of market
conditions the fair value measurement is an exit price concept as defined in
SFAS No. 157, and clarifies and includes additional factors to consider in
determining whether there has been a significant decrease in market activity for
an asset or liability and provides additional clarification on estimating fair
value when the market activity for an asset or liability has declined
significantly. FSP No. 157-4 is applied prospectively to all fair
value measurements where appropriate and will be effective for interim and
annual periods ending after June 15, 2009. Acacia will adopt the
provisions of FSP No. 157-4 effective April 1, 2009. Acacia does not
expect the adoption of FSP No. 157-4 to have a material impact on its
consolidated financial position, results of operations or cash flows.
In April
2009, the FASB issued FSP SFAS No 115-2 and SFAS No. 124-2, “Recognition and
Presentation of Other-Than-Temporary Impairments,” (“FSP No. 115-2 and 124-2”)
which provides operational guidance for determining other-than-temporary
impairments for debt securities. FSP No. 115-2 and 124-2 is effective for
interim and annual periods ending after June 15, 2009 and will be adopted
by Acacia in its interim consolidated financial statements for the quarter ended
June 30, 2009. Management is currently evaluating the impact, if any, of the
adoption of FSP No. 115-2 and 124-2, on Acacia’s consolidated financial
position, results of operations and cash flows.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
In April
2009, the FASB issued FSP SFAS No. 107-1 and APB 28-1, “Interim Disclosures
about Fair Value of Financial Instruments” (“FSP SFAS No. 107 and APB
28-1”). FSP SFAS No.
107 and APB 28-1, which amends SFAS No. 107, “Disclosures about Fair Value of
Financial Instruments,” requires publicly-traded companies, as defined in APB
Opinion No. 28, “Interim Financial Reporting,” to provide disclosures on the
fair value of financial instruments in interim financial
statements. FSP SFAS No. 107-1 and APB 28-1 is effective for interim
periods ending after June 15, 2009. Acacia will adopt the new
disclosure requirements in its interim consolidated financial statements for the
quarter ended June 30, 2009.
In April
2008, the FASB issued FASB Staff Position SFAS No. 142-3, “Determination of
Useful Life of Intangible Assets” (“FSP 142-3”). FSP 142-3 amends the
factors that should be considered in developing the renewal or extension
assumptions used to determine the useful life of a recognized intangible asset
under SFAS No. 142, “Goodwill and Other Intangible Assets.” FSP 142-3
also requires expanded disclosure regarding the determination of intangible
asset useful lives. Acacia adopted FSP 142-3 effective January 1,
2009. The adoption of FSP 142-3 did not have a material impact
on Acacia’s consolidated financial position, results of operations or cash
flows.
In
June 2008, the FASB issued FSP No. EITF 03-6-1, “Determining Whether
Instruments Granted in Share-Based Payment Transactions are Participating
Securities” (“FSP EITF 03-6-1”). FSP EITF 03-6-1 clarifies
whether instruments, such as restricted stock granted in share-based payments
are participating securities prior to vesting. Such participating
securities must be included in the computation of earnings per share under the
two-class method as described in SFAS No. 128, “Earnings per Share.”
FSP EITF 03-6-01 requires companies to treat unvested share-based payment awards
that have non-forfeitable rights to dividend or dividend equivalents as a
separate class of securities in calculating earnings per share. FSP
EITF 03-6-1 is effective for financial statements issued for fiscal years and
interim periods beginning after December 15, 2008, and requires a company
to retrospectively adjust its earnings per share data. Acacia adopted FSP
EITF 03-6-1 effective January 1, 2009. The adoption of FSP EITF
03-6-1 did not have a material impact on Acacia’s current and or prior period
loss per share computations.
Item
2. MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
Cautionary
Statement
You
should read the following discussion and analysis in conjunction with the
consolidated financial statements and related notes thereto contained in Part I,
Item 1 of this Quarterly Report on Form 10-Q. The information contained in this
Quarterly Report on Form 10-Q is not a complete description of our business or
the risks associated with an investment in our common stock. We urge you to
carefully review and consider the various disclosures made by us in this report
and in our other reports filed with the Securities and Exchange Commission, or
the SEC, including our Annual Report on Form 10-K for the year ended December
31, 2008, filed with the SEC on February 26, 2009.
This
Quarterly Report on Form 10-Q contains forward-looking statements that have been
made pursuant to the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995 and concern matters that involve risks and
uncertainties that could cause actual results to differ materially from those
projected in the forward-looking statements. Reference is made in particular to
the description of our plans and objectives for future operations, assumptions
underlying such plans and objectives, and other forward-looking statements set
forth under “Management’s Discussion and Analysis of Financial Condition and
Results of Operations” and other sections of this Quarterly Report on Form 10-Q.
Such statements may be identified by the use of forward-looking terminology such
as “may,” “will,” “should,” “could,” “expect,” “plan,” “believe,” “estimate,”
“anticipate,” “intend,” “predict,” “potential,” “continue,” or similar terms,
variations of such terms or the negative of such terms, although not all
forward-looking statements contain these terms. Such statements are based on
management’s current expectations and are subject to a number of factors and
uncertainties, which could cause actual results to differ materially from those
described in the forward-looking statements. Such statements address future
events and conditions concerning intellectual property acquisition and
development, licensing and enforcement activities, capital expenditures,
earnings, litigation, regulatory matters, markets for services, liquidity and
capital resources and accounting matters. Actual results in each case could
differ materially from those anticipated in such statements by reason of factors
such as future economic conditions, changes in demand for our services,
legislative, regulatory and competitive developments in markets in which we and
our subsidiaries operate, results of litigation and other circumstances
affecting anticipated revenues and costs. We expressly disclaim any intent,
obligation or undertaking to update or revise any forward-looking statements
contained herein to conform such statements to actual results or to reflect any
change in our expectations with regard thereto or any change in events,
conditions or circumstances on which any such statement is based. Readers are
urged to carefully review and consider the various disclosures made by us, which
attempt to advise interested parties of the risks, uncertainties, and other
factors that affect our business, including without limitation the disclosures
made under the captions “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and “Financial Statements” in this
Quarterly Report on Form 10-Q and the audited financial statements and the notes
thereto and disclosures made under the captions “Management Discussion and
Analysis of Financial Condition and Results of Operations,” “Risk Factors”
and “Financial Statements and Supplementary Data” included in our
Annual Report on Form 10-K for the year ended December 31, 2008.
General
As used
in this Quarterly Report on Form 10-Q, “we,” “us” and “our” refer to Acacia
Research Corporation, a Delaware corporation, and/or its wholly-owned operating
subsidiaries. All intellectual property acquisition, development, licensing
and enforcement activities are conducted solely by certain of Acacia Research
Corporation’s wholly-owned operating subsidiaries.
Our
operating subsidiaries acquire, develop, license and enforce patented
technologies. Our operating subsidiaries generate license fee revenues and
related cash flows from the granting of licenses for the use of patented
technologies that our operating subsidiaries own or control. Our operating
subsidiaries assist patent owners with the prosecution and development of their
patent portfolios, the protection of their patented inventions from unauthorized
use, the generation of licensing revenue from users of their patented
technologies and, if necessary, with the enforcement against unauthorized users
of their patented technologies.
We are a
leader in licensing patented technologies and have established a proven track
record of licensing success with over 650 license agreements executed to date,
across 52 of our technology license programs. On a consolidated basis, our
operating subsidiaries own or control the rights to over 100 patent portfolios,
which include U.S. patents and certain foreign counterparts, covering
technologies used in a wide variety of industries.
We were
originally incorporated in California in January 1993 and reincorporated in
Delaware in December 1999.
Overview
Our
operating activities during the three months ended March 31, 2009 and 2008 were
principally focused on the continued development, licensing and enforcement of
the patent portfolios owned or controlled by our operating subsidiaries,
including the continued pursuit of multiple ongoing technology licensing and
enforcement programs and the commencement of new technology licensing
and enforcement programs. In addition, we continued our focus on
business development, including the acquisition of several additional patent
portfolios by certain of our operating subsidiaries and the continued pursuit of
additional opportunities to partner with patent owners and provide our unique
intellectual property licensing, development and enforcement
services.
License
fee revenues recognized for the three months ended March 31, 2009 totaled $12.7
million, as compared to $9.0 million for the three months ended March 31,
2008.
Revenues
for the three months ended March 31, 2009 included license fees from 28 new
licensing agreements covering 16 of our technology licensing and enforcement
programs, as compared to 24 new licensing agreements covering 12 of our
technology licensing and enforcement programs for the three months ended March
31, 2008. On a consolidated basis, our operating subsidiaries
generated licensing revenues from four new technology licensing and enforcement
programs during the three months ended March 31, 2009 and 2008. As of
March 31, 2009, we have generated revenues from 52 technology licensing and
enforcement programs, as compared to 48 programs as of December 31, 2008, and 32
programs as of March 31, 2008.
During
the three months ended March 31, 2009, we recorded initial license fee revenues
from four new technology licensing programs, including our Surgical Catheter
technology, Encrypted Media & Playback Devices technology, Child-friendly
Secure Mobile Phones technology and Heated Surgical Blades
technology. Revenues for the three months ended March 31, 2009 also
included fees from the licensing of our DMT® technology, Telematics technology,
Pop-up Internet Advertising technology, Audio Communications Fraud
Detection technology, Picture Archiving & Communication Systems technology,
Remote Management of Imaging Devices technology, Projector technology, Rule
Based Monitoring technology, Location Based Services technology, Online Auction
Guarantee technology, eCommerce Pricing technology, and High Quality Image
Processing technology.
During
the three months ended March 31, 2008, we recorded initial license fees from
four new technology licensing and enforcement programs, including our Electronic
Message Advertising technology, Remote Management of Imaging Devices technology,
High Quality Image Processing technology, and Wireless
Traffic Information technology licensing programs. Revenues for the
three months ended March 31, 2008 also included fees from the licensing of our
DMT® technology, Pop-Up Internet Advertising technology, Telematics technology,
Rule Based Monitoring technology, Portable Storage Devices with Links
technology, Image Resolution Enhancement technology, and Electronic Address List
Management technology licensing programs.
Our
revenues historically have fluctuated quarterly based on the number of patented
technology portfolios owned or controlled by our operating subsidiaries, the
timing and results of patent filings and other enforcement proceedings relating
to our intellectual property rights, the number of active licensing programs,
and the relative maturity of active licensing programs during the applicable
periods. Additional factors impacting the amount of license fee
revenues recognized each period are included below.
We
measure and assess the performance and growth of our patent licensing and
enforcement business conducted by our operating subsidiaries based on
consolidated license fee revenues recognized across all of our technology
licensing and enforcement programs on a trailing twelve-month
basis. Trailing twelve-month revenues totaled $51.8 million as of
March 31, 2009, as compared to $48.2 million as of December 31, 2008, $42.0
million as of September 30, 2008, $37.7 million as of June 30, 2008, and $36.5
million as of March 31, 2008.
The
consolidated net loss was $2.4 million for the three months ended March 31,
2009, as compared to $4.5 million for the three months ended March 31,
2008. Results for the three months ended March 31, 2009 included
non-cash charges totaling $3.0 million, comprised of non-cash stock compensation
charges of $1.9 million and non-cash patent amortization charges of $1.1
million. Results for the three months ended March 31, 2008
included non-cash charges of $3.2 million, comprised of non-cash stock
compensation charges of $1.8 million and non-cash patent amortization charges of
$1.3 million.
Marketing,
general and administrative expenses for the three months ended March 31, 2009
decreased to $5.4 million, including non-cash stock compensation charges of $1.9
million, from $5.6 million, including non-cash stock compensation charges of
$1.8 million, for the three months ended March 31, 2008, due primarily to a
reduction in personnel costs resulting from a reduction in employee headcount
since the end of the prior year period, and a decrease in accounting and other
corporate, general and administrative costs related to ongoing
operations.
In the
aggregate, inventor royalties and contingent legal fees expenses increased 41%
during the three months ended March 31, 2009, as compared to the three months
ended March 31, 2008, consistent with the 40% increase in related license fee
revenues for the same periods, as discussed above.
We pursue
enforcement actions in connection with our licensing and enforcement programs
which can involve certain risks and uncertainties, including the
following:
·
|
Increases
in patent-related legal expenses, including, but not limited to, increases
in costs billed by outside legal counsel for discovery, depositions,
economic analyses, damages assessments, expert witnesses and other
consultants, case-related audio/video presentations and other litigation
support and administrative costs, could increase our operating costs and
decrease our revenue generating
opportunities;
|
·
|
Trial
courts may be unable to understand complex enforcement actions, and, as a
result, we may be required to appeal adverse decisions by trial courts in
order to successfully enforce our
patents;
|
·
|
New
legislation, regulations or rules related to enforcement actions could
significantly increase our operating costs and decrease our revenue
generating opportunities; and
|
·
|
Courts may rule that our subsidiaries have
violated certain statutory, regulatory, federal, local or governing rules
or standards by pursuing such enforcement actions, which may expose us and
our operating subsidiaries to material liabilities, which could harm our
operating results and our financial
position.
|
During
the three months ended March 31, 2009, certain of our operating subsidiaries
continued to execute their business strategy in the area of patent portfolio
acquisitions, including the acquisition of, or the acquisition of the rights to
five patent portfolios covering a variety of applications, including the
following three portfolios described below:
|
·
|
Online
Promotion. This patented technology generally relates to
online promotion of consumer products and can be used to provide consumers
with web access to discount coupons and rebate
offers.
|
|
·
|
Interactive
Mapping. This patented technology generally relates to
interactive maps and can be used to provide user-generated data, such as
places of interest or reviews, over the
Internet.
|
|
·
|
Improved Anti-Trap
Safety. This patented technology can be used to adapt automatic
vent closure to changes, such as environment or mechanical wear. This
technology may be applicable to vehicles that implement
anti-pinch/anti-trap safety systems on powered vents such as windows,
doors and sunroofs.
|
Refer to
“Liquidity and Capital Resources” below for information regarding the impact of
patent and patent rights acquisitions on the Consolidated Financial Statements
for the periods presented.
As of
March 31, 2009, on a consolidated basis, our operating subsidiaries owned or
controlled the rights to over 100 patent portfolios, as compared to 91 patent
portfolios as of March 31, 2008.
As of
March 31, 2009, certain of our operating subsidiaries had several option
agreements with third-party patent portfolio owners regarding the potential
acquisition of additional patent portfolios. Future patent portfolio
acquisitions will continue to expand and diversify our future revenue generating
opportunities.
Critical
Accounting Estimates
Our
unaudited interim financial statements have been prepared in accordance with
accounting principles generally accepted in the United States of America.
Preparation of these statements requires management to make judgments and
estimates. Some accounting policies have a significant impact on amounts
reported in these financial statements. A summary of significant accounting
policies and a description of accounting policies that are considered critical
may be found in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2008, filed with the SEC on February 26, 2009, in the Notes to the
Consolidated Financial Statements and the Critical Accounting Estimates
section. In addition, refer to Note 2 to the Consolidated Financial
Statements included in this report.
Comparison
of the Results of Operations for the Three Months Ended March 31, 2009 and
2008
Net
Loss (In thousands)
|
|
For
the Three Months Ended
|
|
|
|
March
31,
2009
|
|
|
March
31,
2008
|
|
Net
loss
|
|
$ |
(2,357 |
) |
|
$ |
(4,489 |
) |
The
changes in net loss were primarily due to the operating results and activities
for the periods presented as discussed below.
Revenue
(In thousands)
|
|
For
the Three Months Ended
|
|
|
|
March
31,
2009
|
|
|
March
31,
2008
|
|
License
fees
|
|
$ |
12,650 |
|
|
$ |
9,048 |
|
License Fees. Revenues for
the three months ended March 31, 2009 included license fees from 28 new
licensing agreements covering 16 of our technology licensing and enforcement
programs, as compared to 24 new licensing agreements covering 12 of our
technology licensing and enforcement programs in the same period in
2008. Three licensees accounted for
20%, 11% and 10% of license fee revenues recognized during the three months
ended March 31, 2009, and one licensee accounted for
28% and three licensees individually accounted for 10% of license fee revenues
recognized during the three months ended March 31, 2008. The increase
in license fee revenues was due to an increase in the number of license
agreements executed and an increase in the average revenue per license agreement
executed during the three months ended March 31, 2009, as compared to the three
months ended March 31, 2008.
License
fee revenues recognized by our operating subsidiaries fluctuate from period to
period primarily based on the following factors:
|
·
|
the
dollar amount of agreements executed each period, which is primarily
driven by the nature and characteristics of the technology being licensed
and the magnitude of infringement associated with a specific
licensee;
|
|
·
|
the
specific terms and conditions of agreements executed each period and the
periods of infringement contemplated by the respective
payments;
|
|
·
|
fluctuations
in the total number of agreements
executed;
|
|
·
|
fluctuations
in the sales results or other royalty per unit activities of our licensees
that impact the calculation of license fees
due;
|
|
·
|
the
timing of the receipt of periodic license fee payments and/or reports from
licensees; and
|
|
·
|
fluctuations
in the net number of active licensees period to
period.
|
Deferred
license fee revenues, representing upfront license fee payments received from
licensees at the beginning of the contractual license term, which are deferred
and amortized in the statements of operations as license fee revenues on a
straight-line basis over the applicable license term, increased to $4.3 million
at March 31, 2009, compared to $318,000 at December 31, 2008. Related
deferred royalties and contingent legal fees expense, which are also amortized
in the statements of operations on a straight-line basis over the applicable
license term, totaled $1.6 million at March 31, 2009. The noncurrent
portion of deferred royalties and contingent legal fees, totaling $615,000 is
included in “Other assets – noncurrent.”
Operating
Expenses (In thousands)
|
|
For
the Three Months Ended
|
|
|
|
March
31,
2009
|
|
|
March
31,
2008
|
|
|
|
|
|
|
|
|
Marketing,
general and administrative expenses (including non-cash stock compensation
expense
of $1,920 and $1,829 for the three months ended March 31, 2009 and 2008,
respectively)
|
|
$ |
5,378 |
|
|
$ |
5,649 |
|
Inventor
royalties and contingent legal fees expense - patents
|
|
|
6,691 |
|
|
|
4,731 |
|
Legal
expenses - patents
|
|
|
1,361 |
|
|
|
1,016 |
|
Research,
consulting and other expenses - patents
|
|
|
761 |
|
|
|
977 |
|
Amortization
of patents
|
|
|
1,065 |
|
|
|
1,335 |
|
Marketing, General and
Administrative Expenses. Marketing, general and administrative
expenses include employee compensation and related personnel costs, including
non-cash stock compensation expenses, office and facilities costs, legal
and accounting professional fees, public relations, marketing, stock
administration and other corporate costs.
A summary of the main drivers of the
change in marketing, general and administrative expenses, including the impact
of non-cash stock compensation charges, for the periods presented, is as follows
(in thousands):
|
|
For
the
Three
Months
|
|
|
|
Ended
March
31,
|
|
|
|
2009
vs. 2008
|
|
Net
reduction of licensing, business development and engineering personnel
|
|
$ |
(75 |
) |
One
time employee severance charges
|
|
|
163 |
|
Corporate,
general and administrative costs
|
|
|
(449 |
) |
Non-cash
stock compensation expense
|
|
|
90 |
|
Inventor Royalties and Contingent
Legal Fees Expense. Inventor royalties expense totaled $3.5
million and $2.1 million for the three months ended March 31, 2009 and 2008,
respectively, and contingent legal fees expense totaled $3.2 million and $2.6
million for the three months ended March 31, 2009 and 2008,
respectively. The majority of the patent portfolios owned or
controlled by our operating subsidiaries are subject to patent and patent rights
agreements with inventors containing provisions granting to the original patent
owner the right to receive inventor royalties based on future net revenues, as
defined in the respective agreements, and may also be subject to contingent
legal fee arrangements with external law firms engaged on a contingent fee
basis. The economic terms of the inventor and contingent fee
arrangements, if any, vary across our patent portfolios. As such,
inventor royalties and contingent legal fees expenses fluctuate period to period
based on the amount of revenues recognized each period and the mix of specific
patent portfolios, with varying economic terms, generating revenues each
period.
In the
aggregate, inventor royalties and contingent legal fees expenses increased 41%
during the three months ended March 31, 2009, as compared to the three months
ended March 31, 2008, consistent with the 40% increase in related license fee
revenues for the same periods. For the same periods, inventor
royalties expense increased 69%, compared to the 40% increase in license fee
revenues, due primarily to certain patent portfolios with lower than average
inventor royalty rates generating revenues during the three months ended March
31, 2008, as compared to the patent portfolios generating revenues during the
three months ended March 31, 2009. For the same periods, contingent
legal fees expenses increased 20%, compared to the 40% increase in license fee
revenues, due to certain patent portfolios with lower contingent fee rates
generating revenues during the three months ended March 31, 2009, as compared to
the patent portfolios generating revenues during the three months ended March
31, 2008.
Legal Expense –
Patents. Patent-related legal expenses include patent-related
prosecution and enforcement costs incurred by outside law firms engaged on an
hourly basis and the out-of-pocket expenses incurred by law firms engaged on a
contingent fee basis. Patent-related legal expenses fluctuate from
period to period based on patent enforcement and prosecution activity associated
with ongoing licensing and enforcement programs and the timing of the
commencement of new licensing and enforcement programs in each
period. The increase during the three months ended March 31, 2009, as
compared to the three months ended March 31, 2008, is primarily due to patent
related legal expenses incurred on new licensing and enforcement programs
commenced since the end of the prior year period. We expect
patent-related legal expenses to continue to fluctuate quarter to quarter based
on the factors summarized above, in connection with our current and future
patent acquisition, development, licensing and enforcement
activities.
Research, Consulting and Other
Expenses - Patents. Research, consulting and other expenses
include third-party patent related research, development, consulting, licensing
and patent maintenance costs incurred in connection with the identification,
review, acquisition, development, licensing and enforcement and maintenance of
patent portfolios. These costs fluctuate period to period based on
business development, patent related research, due diligence and patent
licensing and enforcement activities in each period. The decrease
during the three months ended March 31, 2009, as compared to the three months
ended March 31, 2008, is primarily due to a reduction in expenses related to
certain licensing and enforcement programs that are further along in the related
litigation and enforcement effort. This reduction was partially
offset by an increase in expenses incurred in connection with new patent related
business development and licensing and enforcement programs commenced since the
end of the prior year period. We expect patent related research,
consulting and other expenses to continue to fluctuate quarter to quarter based
on the factors summarized above, in connection with our current and future
patent acquisition, development, licensing and enforcement
activities.
Other
At March
31, 2009, the par value of auction rate securities collateralized by student
loan portfolios totaled $2,700,000. As a result of the liquidity issues
discussed at Note 7 to the Consolidated Financial Statements included in this
report, we estimated that the fair value of these auction rate securities no
longer approximated their par value. These securities continue to be AAA rated.
However, as a result of the analysis described at Note 7 to the Consolidated
Financial Statements included in this report, we recorded an
other-than-temporary loss of $263,000 in the accompanying statement of
operations for the three months ended March 31, 2008. As a result of
partial redemptions at par on certain of these auction rate securities
subsequent to March 31, 2008, we recovered $23,000 of the other-than-temporary
loss originally recorded on these securities. As of March 31, 2009,
the net other-than-temporary loss on auction rate securities collateralized by
student loan portfolios totaled $240,000.
At March
31, 2009, the par value of auction rate securities issued by high credit quality
closed-end investment companies totaled $875,000. Despite the reduction in
liquidity resulting from the failure of auctions for these securities since
February 2008, the issuers of these auction rate securities have redeemed, at
par, approximately 71% of the securities held by us since February 2008, and
have indicated that they continue to evaluate ways to provide additional
liquidity to their auction rate security holders. Additionally, these securities
continue to be AAA rated and the underlying funds continue to meet certain
specified asset coverage tests required by the rating agencies, as well as the
200% asset coverage test with respect to auction rate securities set forth in
the Investment Company Act of 1940, as amended. However, as a result of the
analysis discussed at Note 7 to the Consolidated Financial Statements included
in this report, we recorded an other-than-temporary loss on auction rate
securities issued by high credit quality closed-end investment companies of
$236,000 in the statement of operations for the three months ended December 31,
2008. As a result of partial redemptions at par on certain of these
auction rate securities during the three months ended March 31, 2009, we
recovered $24,000 of the other-than-temporary loss originally recorded on these
securities. As of March 31, 2009, the net other-than-temporary loss
on auction rate securities issued by high credit quality closed-end investment
companies totaled $212,000.
Inflation
Inflation
has not had a significant impact on Acacia Research Corporation or its
subsidiaries.
Liquidity
and Capital Resources
Our
consolidated cash and cash equivalents and investments totaled
$54.0 million at March 31, 2009, compared to $51.5 million at
December 31, 2008. Working capital at March 31, 2009 was $43.4 million,
compared to $42.6 million at December 31, 2008.
The net
increase (decrease) in cash and cash equivalents related to operations for the
periods presented was comprised of the following (in thousands):
|
|
For
the Three Months Ended
|
|
|
|
March
31,
2009
|
|
|
March
31,
2008
|
|
Net
cash provided by (used in):
|
|
|
|
|
|
|
Operating
activities
|
|
$ |
2,618 |
|
|
$ |
(3,878 |
) |
Investing
activities
|
|
|
(19 |
) |
|
|
3,383 |
|
Financing
activities
|
|
|
- |
|
|
|
111 |
|
Cash Flows from Operating
Activities. Cash receipts from licensees for the three months ended
March 31, 2009 increased to $14.7 million, from $6.2 million in the
comparable 2008 period. Cash outflows from operations for the three
months ended March 31, 2009 increased to $12.1 million, as
compared to $10.1 million in the comparable 2008 period, due to the net increase
in operating expenses, as discussed above, and the impact of the timing of
payments to inventors, attorneys and other vendors. Accounts
receivable increased to $9.4 million at March 31, 2009, compared to $7.4 million
at December 31, 2008.
Cash Flows from Investing
Activities. The change in net cash flows used in investing
activities was primarily due to net purchases and sales of available-for-sale
investments in connection with ongoing short-term cash management activities
during the periods presented. Net cash outflows from investing
activities for the three months ended March 31, 2009 also included patent
related acquisition costs totaling $162,000, as compared to $1,558,000 in the
comparable 2008 period.
Cash Flows from Continuing Financing
Activities. Net cash flows provided by financing activities
during the three months ended March 31, 2008 included proceeds from the exercise
of Acacia Research Corporation common stock options totaling
$111,000.
Our
management believes that the cash and cash equivalent balances, investments,
anticipated cash flow from operations and other external sources of available
credit, will be sufficient to meet our cash requirements through at least May
2010 and for the foreseeable future. We may however encounter unforeseen
difficulties that may deplete our capital
resources more rapidly than anticipated, including those set forth under the
caption “Risk Factors” beginning on page 6 of our Annual Report on Form 10-K for
the year ended December 31, 2008, filed with the SEC on February 26, 2009. Any
efforts to seek additional funding could be made through equity, debt or other
external financing; however, there can be no assurance that additional funding
will be available on favorable terms, if at all. The capital and credit markets
have been experiencing extreme volatility and disruption for more than 12
months. Recently, the volatility and disruption have reached unprecedented
levels. In several cases, the markets have exerted downward pressure on stock
prices and credit capacity for certain issuers, and there can be no assurance
that the commercial paper markets will be a reliable source of short-term
financing for us. If we fail to obtain additional funding when needed, we may
not be able to execute our business plans and our business may suffer.
Off-Balance
Sheet Arrangements
We have
not entered into off-balance sheet financing arrangements, other than operating
leases. We have no significant commitments for capital expenditures
in 2009. We have no committed lines of credit or other committed
funding or long-term debt. The following table lists our material
known future cash commitments as of March 31, 2009:
|
|
Payments
Due by Period (In thousands)
|
|
Contractual
Obligations
|
|
Total
|
|
|
Less
than
1
year
|
|
|
1-3
years
|
|
|
3-5
years
|
|
|
More
than 5
years
|
|
Operating
leases
|
|
$ |
2,720 |
|
|
$ |
633 |
|
|
$ |
1,923 |
|
|
$ |
164 |
|
|
$ |
- |
|
Total
contractual obligations
|
|
$ |
2,720 |
|
|
$ |
633 |
|
|
$ |
1,923 |
|
|
$ |
164 |
|
|
$ |
- |
|
FIN 48
Liability. As of March 31, 2009, the liability for uncertain
tax positions, associated primarily with state income taxes, was $75,000, of
which none is expected to be paid within one year. The liability for uncertain
tax positions is recorded in other long-term liabilities in the consolidated
balance sheet.
Recent
Accounting Pronouncements
Refer to
Note 2 and Note 8 to the Consolidated Financial Statements included in this
report.
Item
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
The
primary objective of our investment activities is to preserve principal while
concurrently maximizing the income we receive from our investments without
significantly increasing risk. Some of the securities that we may invest in may
be subject to market risk. This means that a change in prevailing interest rates
may cause the principal amount of the investment to fluctuate. For example, if
we hold a security that was issued with a fixed interest rate at the
then-prevailing rate and the prevailing interest rate later rises, the current
value of the principal amount of our investment will decline. To minimize this
risk in the future, we intend to maintain our portfolio of cash equivalents and
short-term investments in a variety of securities, including commercial paper,
money market funds, high-grade corporate bonds, government and non-government
debt securities and certificates of deposit. In general, money market funds are
not subject to market risk because the interest paid on such funds fluctuates
with the prevailing interest rate. As of March 31, 2009, our investments were
comprised of money market funds and auction rate securities. A hypothetical 100
basis point increase in interest rates would not have a material impact on the
fair value of our available-for-sale securities as of March 31,
2009. Refer to “Liquidity and Capital Resources” and Note 7 to the
Consolidated Financial Statements included in this report for additional
information.
Item
4. CONTROLS AND PROCEDURES
Evaluation
of Disclosure Controls and Procedures
Under the
supervision and with the participation of our management, including our chief
executive officer and chief financial officer, we conducted an evaluation of our
disclosure controls and procedures, as such term is defined under
Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as
amended, or the Exchange Act. Based on this evaluation, our chief executive
officer and our chief financial officer concluded that, as of the end of the
period covered by this quarterly report, our disclosure controls and procedures
were effective to ensure that the information required to be disclosed by us in
the reports that we file or submit under the Exchange Act is accumulated and
communicated to management, including our chief executive officer and chief
financial officer, to allow timely decisions regarding required disclosure, and
that such information is recorded, processed, summarized and reported within the
time periods prescribed by the SEC.
Changes
in Internal Control Over Financial Reporting
(a) There
were no changes in our internal control over financial reporting that occurred
during our last fiscal quarter (the quarter ended March 31, 2009) that have
materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.
PART
II--OTHER INFORMATION
Item
6. EXHIBITS
31.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
32.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
32.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
___________________
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
ACACIA
RESEARCH CORPORATION
|
|
|
|
|
|
By: /s/ Paul R.
Ryan
|
|
Paul
R. Ryan
|
|
Chief
Executive Officer
|
|
|
|
|
|
|
|
By: /s/ Clayton
J.
Haynes
|
|
Clayton
J. Haynes
|
|
Chief
Financial Officer and Treasurer
|
|
|
Date: May
7, 2009
EXHIBIT
INDEX
EXHIBIT
NUMBER
|
EXHIBIT
|
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
32.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
32.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
___________________
20